The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Diabetic Lancing Device Market Research Report 2025

Global Diabetic Lancing Device Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1432078

No of Pages : 102

Ask Your Query

Synopsis

Diabetes is a global epidemic affecting an estimated 382 million people worldwide. The WHO projects that diabetes will be the 7th leading cause of death by 2030. An estimated 4 million people die annually from the complications associated with diabetes. Therefore, if the current trend associated with the prevalence of diabetes continues over the coming years, the number of diabetic patients across the globe would be tremendous after a decade.

The global Diabetic Lancing Device market was valued at US$ 127640 million in 2023 and is anticipated to reach US$ 208130 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.

Increasing prevalence of diabetes will result in the rising demand for devices and products to monitor and control diabetes, eventually leading to increased consumption of lancets. Thus, the demand for lancets is expected to be enormous in the coming future.

This report aims to provide a comprehensive presentation of the global market for Diabetic Lancing Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Lancing Device.

Report Scope

The Diabetic Lancing Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Lancing Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diabetic Lancing Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

By Company

  • B. Braun
  • Terumo Corporation
  • Becton Dickinson
  • Sanofi
  • Roche
  • Bayer
  • Novo Nordisk
  • Eli Lilly
  • Medtronic
  • Ypsomed Holding
  • Sarstedt
  • Abbott Laboratories
  • HTL-STREFA
  • Improve Medical
  • UltiMed
  • Allison Medical
  • Artsana

Segment by Type

  • Push Button Safety Lancets
  • Pressure Activated Safety Lancets
  • Side Button Safety Lancets

Segment by Application

  • Hospitals
  • Clinics

Consumption by Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diabetic Lancing Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diabetic Lancing Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Diabetic Lancing Device Market Overview
1.1 Product Overview and Scope of Diabetic Lancing Device
1.2 Diabetic Lancing Device Segment by Type
1.2.1 Global Diabetic Lancing Device Market Value Comparison by Type (2024-2030)
1.2.2 Push Button Safety Lancets
1.2.3 Pressure Activated Safety Lancets
1.2.4 Side Button Safety Lancets
1.3 Diabetic Lancing Device Segment by Application
1.3.1 Global Diabetic Lancing Device Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Diabetic Lancing Device Market Size Estimates and Forecasts
1.4.1 Global Diabetic Lancing Device Revenue 2019-2030
1.4.2 Global Diabetic Lancing Device Sales 2019-2030
1.4.3 Global Diabetic Lancing Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diabetic Lancing Device Market Competition by Manufacturers
2.1 Global Diabetic Lancing Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diabetic Lancing Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diabetic Lancing Device Average Price by Manufacturers (2019-2024)
2.4 Global Diabetic Lancing Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diabetic Lancing Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diabetic Lancing Device, Product Type & Application
2.7 Diabetic Lancing Device Market Competitive Situation and Trends
2.7.1 Diabetic Lancing Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diabetic Lancing Device Players Market Share by Revenue
2.7.3 Global Diabetic Lancing Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetic Lancing Device Retrospective Market Scenario by Region
3.1 Global Diabetic Lancing Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diabetic Lancing Device Global Diabetic Lancing Device Sales by Region: 2019-2030
3.2.1 Global Diabetic Lancing Device Sales by Region: 2019-2024
3.2.2 Global Diabetic Lancing Device Sales by Region: 2025-2030
3.3 Global Diabetic Lancing Device Global Diabetic Lancing Device Revenue by Region: 2019-2030
3.3.1 Global Diabetic Lancing Device Revenue by Region: 2019-2024
3.3.2 Global Diabetic Lancing Device Revenue by Region: 2025-2030
3.4 North America Diabetic Lancing Device Market Facts & Figures by Country
3.4.1 North America Diabetic Lancing Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diabetic Lancing Device Sales by Country (2019-2030)
3.4.3 North America Diabetic Lancing Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diabetic Lancing Device Market Facts & Figures by Country
3.5.1 Europe Diabetic Lancing Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diabetic Lancing Device Sales by Country (2019-2030)
3.5.3 Europe Diabetic Lancing Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diabetic Lancing Device Market Facts & Figures by Country
3.6.1 Asia Pacific Diabetic Lancing Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diabetic Lancing Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Diabetic Lancing Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diabetic Lancing Device Market Facts & Figures by Country
3.7.1 Latin America Diabetic Lancing Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diabetic Lancing Device Sales by Country (2019-2030)
3.7.3 Latin America Diabetic Lancing Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diabetic Lancing Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Diabetic Lancing Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diabetic Lancing Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diabetic Lancing Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Diabetic Lancing Device Sales by Type (2019-2030)
4.1.1 Global Diabetic Lancing Device Sales by Type (2019-2024)
4.1.2 Global Diabetic Lancing Device Sales by Type (2025-2030)
4.1.3 Global Diabetic Lancing Device Sales Market Share by Type (2019-2030)
4.2 Global Diabetic Lancing Device Revenue by Type (2019-2030)
4.2.1 Global Diabetic Lancing Device Revenue by Type (2019-2024)
4.2.2 Global Diabetic Lancing Device Revenue by Type (2025-2030)
4.2.3 Global Diabetic Lancing Device Revenue Market Share by Type (2019-2030)
4.3 Global Diabetic Lancing Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diabetic Lancing Device Sales by Application (2019-2030)
5.1.1 Global Diabetic Lancing Device Sales by Application (2019-2024)
5.1.2 Global Diabetic Lancing Device Sales by Application (2025-2030)
5.1.3 Global Diabetic Lancing Device Sales Market Share by Application (2019-2030)
5.2 Global Diabetic Lancing Device Revenue by Application (2019-2030)
5.2.1 Global Diabetic Lancing Device Revenue by Application (2019-2024)
5.2.2 Global Diabetic Lancing Device Revenue by Application (2025-2030)
5.2.3 Global Diabetic Lancing Device Revenue Market Share by Application (2019-2030)
5.3 Global Diabetic Lancing Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Corporation Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 B. Braun Diabetic Lancing Device Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Terumo Corporation
6.2.1 Terumo Corporation Corporation Information
6.2.2 Terumo Corporation Description and Business Overview
6.2.3 Terumo Corporation Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Terumo Corporation Diabetic Lancing Device Product Portfolio
6.2.5 Terumo Corporation Recent Developments/Updates
6.3 Becton Dickinson
6.3.1 Becton Dickinson Corporation Information
6.3.2 Becton Dickinson Description and Business Overview
6.3.3 Becton Dickinson Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Becton Dickinson Diabetic Lancing Device Product Portfolio
6.3.5 Becton Dickinson Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Diabetic Lancing Device Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Roche Diabetic Lancing Device Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer Diabetic Lancing Device Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novo Nordisk Diabetic Lancing Device Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Description and Business Overview
6.8.3 Eli Lilly Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Eli Lilly Diabetic Lancing Device Product Portfolio
6.8.5 Eli Lilly Recent Developments/Updates
6.9 Medtronic
6.9.1 Medtronic Corporation Information
6.9.2 Medtronic Description and Business Overview
6.9.3 Medtronic Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Medtronic Diabetic Lancing Device Product Portfolio
6.9.5 Medtronic Recent Developments/Updates
6.10 Ypsomed Holding
6.10.1 Ypsomed Holding Corporation Information
6.10.2 Ypsomed Holding Description and Business Overview
6.10.3 Ypsomed Holding Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ypsomed Holding Diabetic Lancing Device Product Portfolio
6.10.5 Ypsomed Holding Recent Developments/Updates
6.11 Sarstedt
6.11.1 Sarstedt Corporation Information
6.11.2 Sarstedt Diabetic Lancing Device Description and Business Overview
6.11.3 Sarstedt Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sarstedt Diabetic Lancing Device Product Portfolio
6.11.5 Sarstedt Recent Developments/Updates
6.12 Abbott Laboratories
6.12.1 Abbott Laboratories Corporation Information
6.12.2 Abbott Laboratories Diabetic Lancing Device Description and Business Overview
6.12.3 Abbott Laboratories Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Abbott Laboratories Diabetic Lancing Device Product Portfolio
6.12.5 Abbott Laboratories Recent Developments/Updates
6.13 HTL-STREFA
6.13.1 HTL-STREFA Corporation Information
6.13.2 HTL-STREFA Diabetic Lancing Device Description and Business Overview
6.13.3 HTL-STREFA Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 HTL-STREFA Diabetic Lancing Device Product Portfolio
6.13.5 HTL-STREFA Recent Developments/Updates
6.14 Improve Medical
6.14.1 Improve Medical Corporation Information
6.14.2 Improve Medical Diabetic Lancing Device Description and Business Overview
6.14.3 Improve Medical Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Improve Medical Diabetic Lancing Device Product Portfolio
6.14.5 Improve Medical Recent Developments/Updates
6.15 UltiMed
6.15.1 UltiMed Corporation Information
6.15.2 UltiMed Diabetic Lancing Device Description and Business Overview
6.15.3 UltiMed Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 UltiMed Diabetic Lancing Device Product Portfolio
6.15.5 UltiMed Recent Developments/Updates
6.16 Allison Medical
6.16.1 Allison Medical Corporation Information
6.16.2 Allison Medical Diabetic Lancing Device Description and Business Overview
6.16.3 Allison Medical Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Allison Medical Diabetic Lancing Device Product Portfolio
6.16.5 Allison Medical Recent Developments/Updates
6.17 Artsana
6.17.1 Artsana Corporation Information
6.17.2 Artsana Diabetic Lancing Device Description and Business Overview
6.17.3 Artsana Diabetic Lancing Device Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Artsana Diabetic Lancing Device Product Portfolio
6.17.5 Artsana Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diabetic Lancing Device Industry Chain Analysis
7.2 Diabetic Lancing Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diabetic Lancing Device Production Mode & Process
7.4 Diabetic Lancing Device Sales and Marketing
7.4.1 Diabetic Lancing Device Sales Channels
7.4.2 Diabetic Lancing Device Distributors
7.5 Diabetic Lancing Device Customers
8 Diabetic Lancing Device Market Dynamics
8.1 Diabetic Lancing Device Industry Trends
8.2 Diabetic Lancing Device Market Drivers
8.3 Diabetic Lancing Device Market Challenges
8.4 Diabetic Lancing Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock